Radiat Oncol J.
2017 Jun;35(2):112-120. 10.3857/roj.2017.00192.
The role of adjuvant external beam radiation therapy for papillary thyroid carcinoma invading the trachea
- Affiliations
-
- 1Department of Radiation Oncology, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea. gekim@yuhs.ac
- 2Department of Surgery, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
- 3Department of Otorhinolaryngology, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
- 4Department of Nuclear Medicine and Molecular Imaging, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
- 5Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
- 6Department of Pathology, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
- 7Department of Radiation Oncology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
- KMID: 2386208
- DOI: http://doi.org/10.3857/roj.2017.00192
Abstract
- PURPOSE
To evaluate the effect of adjuvant external beam radiation therapy (EBRT) on local failure-free survival rate (LFFS) for papillary thyroid cancer (PTC) invading the trachea.
MATERIALS AND METHODS
Fifty-six patients with locally advanced PTC invading the trachea were treated with surgical resection. After surgery, 21 patients received adjuvant EBRT and radioactive iodine therapy (EBRT group) and 35 patients were treated with radioactive iodine therapy (control group).
RESULTS
The age range was 26-87 years (median, 56 years). The median follow-up period was 43 months (range, 4 to 145 months). EBRT doses ranged from 50.4 to 66 Gy (median, 60 Gy). Esophagus invasion and gross residual disease was more frequent in the EBRT group. In the control group, local recurrence developed in 9 (9/35, 26%) and new distant metastasis in 2 (2/35, 6%) patients, occurring 4 to 68 months (median, 37 months) and 53 to 68 months (median, 60 months) after surgery, respectively. Two patients had simultaneous local recurrence and new distant metastasis. There was one local failure in the EBRT group at 18 months after surgery (1/21, 5%). The 5-year LFFS was 95% in the EBRT group and 63% in the control group (p = 0.103). In the EBRT group, one late grade 2 xerostomia was developed.
CONCLUSION
Although, EBRT group had a higher incidence of esophagus invasion and gross residual disease, EBRT group showed a better 5-year LFFS. Adjuvant EBRT may have contributed to the better LFFS in these patients.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Assessment of management for thyroid carcinoma invading the trachea
- Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 7. Adjuvant External Beam Radiotherapy and Systemic Chemotherapy Following Thyroidectomy 2024
- A Case of Inoperable Advanced Papillary Thyroid Carcinoma Maintaining Long-term Stable Disease State after Palliative Aim Radiation Therapy Alone
- A Case of Occult Papillary Carcinoma of Thyroid, Invaded Trachea and Esophagus
- A Case of Tracheal Defect Reconstruction Using Anterolateral Thigh Free Flap in Patients with Papillary Thyroid Carcinoma Invading Tracheal Cartilage
